Show simple item record

dc.creatorUlloa, Catalina
dc.creatorPereira Céspedes, Alfonso
dc.creatorSoley Gutiérrez, Carolina
dc.creatorPorat, Nurith
dc.creatorAbdelnour Vásquez, Arturo
dc.creatorDagan, Ron
dc.creatorArguedas Mohs, Adriano
dc.date.accessioned2019-06-24T14:59:09Z
dc.date.available2019-06-24T14:59:09Z
dc.date.issued2013
dc.identifier.citationhttps://www.scirp.org/journal/PaperInformation.aspx?PaperID=31502es_ES
dc.identifier.issn2160-5823
dc.identifier.urihttp://hdl.handle.net/10669/77453
dc.description.abstractObjective: The aim of this study was to analyze the NP/OP S. pneumoniae serotype distribution and potential vaccine coverage in Costa Rican children with Otitis Media (OM) before the introduction of PCV-7 in the National Immunization Program (NIP). Methods: Between 2002 and 2006, NP and OP samples were obtained from 641 children from 6 to 79 months of age, at the time of OM diagnosis. S. pneumoniae serotyping and antimicrobial susceptibility were performed. Results: 386 S. pneumoniae isolates were recovered. The most common S. pneumoniae serotypes (ST) were: ST 6B, ST 14, ST 19F. Penicillin non-susceptibility was observed among 57% of the isolates obtained from children < 24 months of age. 15% strains were multidrug resistant. Potential vaccine coverage was: PCV-7: 60%; PCV-10: 62%; and PCV-13: 76% and against penicillin non-susceptible and multidrug resistant isolates was: PCV-7; 59% and 83%, respectively; PCV-10: 60% and 85%, respectively and PCV-13: 74% and 96%, respectively. Conclusions: S. pneumoniae was isolated from the NP and/or OP in the majority (59%) of studied children with OM. At a statistical significant level, only serotype 3 was more frequently isolated among children >24 months of age. Antibiotic non-susceptibility and MDR were significantly higher in children <24 months of age. This study demonstrates that PCV-13 offers the highest potential vaccine coverage and serves to assess the impact of introduction of one of the conjugated vaccines in the NIP in Costa Rica.es_ES
dc.language.isoen_USes_ES
dc.rightsCC0 1.0 Universal*
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.sourceWorld Journal of Vaccines; vol.3(2), pp. 39-45es_ES
dc.subjectStreptococcus pneumoniaees_ES
dc.subjectSerotypeses_ES
dc.subjectNasopharynxes_ES
dc.subjectOropharynxes_ES
dc.subjectPneumococcal Conjugated Vaccinees_ES
dc.subject616. 208 372 86 Enfermedades del sistema respiratorioes_ES
dc.titleStreptococcus pneumoniae Upper Respiratory Carriage in Costa Rican Children with Otitis Media before the Introduction of the Heptavalent Conjugated Vaccine in the National Immunization Programes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doi10.4236/wjv.2013.32007
dc.description.procedenceUCR::Vicerrectoría de Docencia::Salud::Facultad de Farmaciaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC0 1.0 Universal
Except where otherwise noted, this item's license is described as CC0 1.0 Universal